COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1845: Articles 18441-18450  | Next

Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19
Thompson, M. A., Henderson, J. P., Shah, P. K., Rubinstein, S. M., Joyner, M. J., Choueiri, T. K., Flora, D. B., Griffiths, E. A., Gulati, A. P., Hwang, C., Koshkin, V. S., Papadopoulos, E. B., Robilotti, E. V., Su, C. T., Wulff-Burchfield, E. M., Xie, Z., Yu, P. P., Mishra, S., Senefeld, J. W., Shah, D. P., Warner, J. L., COVID-19 and Cancer Consortium
10.1101/2021.02.05.21250953 — Posted: 2021-02-05
Efficacy of Ivermectin in COVID-19 Patients with Mild to Moderate Disease
Bukhari, S. K. H. S., Asghar, A., Perveen, N., Hayat, A., Mangat, S. A., Butt, K. R., Abdullah, M., Fatima, T., Mustafa, A., Cheema, T.
10.1101/2021.02.02.21250840 — Posted: 2021-02-05
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors
Vickers, M., Sariol, A., Leon, J., Ehlers, A., Locher, A., DuBay, K., Collins, L., Voss, D., Odle, A., Holida, M., Merrill, A., Perlman, S., Knudson, M.
10.1101/2021.02.02.21250836 — Posted: 2021-02-05
Can a COVID-19 vaccination program guarantee the return to a pre-pandemic lifestyle?
Yang, J., Marziano, V., Deng, X., Guzzetta, G., Zhang, J., Trentini, F., Cai, J., Poletti, P., Zheng, W., Wang, W., Wu, Q., Zhao, Z., Dong, K., Zhong, G., Viboud, C., Merler, S., Ajelli, M., Yu, H.
10.1101/2021.02.03.21251108 — Posted: 2021-02-05
Pharmacokinetics of Orally Administered GS-441524 in Dogs
Yan, V. C., Khadka, S., Arthur, K., Ackroyd, J. J., Georgiou, D. K., Muller, F. L.
10.1101/2021.02.04.429674 — Posted: 2021-02-05
Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation
Zhang, L., Mann, M., Syed, Z., Reynolds, H. M., Tian, E., Samara, N. L., Zeldin, D. C., Tabak, L. A., Ten Hagen, K. G.
10.1101/2021.02.05.429982 — Posted: 2021-02-05
Serological Profile Of Specific Antibodies Against Dominant Antigens Of SARS-CoV-2 In Chilean COVID-19 Patients.
Cereceda, K., Gonzalez-Stegmaier, R., Briones, J. L., Selman, C., Aguirre, A., Valenzuela-Nieto, G., Caglevic, C., Gazitua, R., Rojas-Fernandez, A., Villaroel-Espindola, F.
10.1101/2021.02.05.429566 — Posted: 2021-02-05
Protein glycosylation is essential for SARS-CoV-2 infection
Casas-Sanchez, A., Romero-Ramirez, A., Hargreaves, E., Patterson, E. I., Hughes, G. L., Zech, T., Acosta-Serrano, A.
10.1101/2021.02.05.429940 — Posted: 2021-02-05 Discussion: Onsite
Post-infection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection
Dampalla, C., Zheng, J., Perera, K., Wong, L. Y. R., Meyerholz, D., Nguyen, H., Kashipathy, M., Battaile, K., Lovell, S., Kim, Y., Perlman, S., Groutas, W., Chang, K.-O.
10.1101/2021.02.05.429937 — Posted: 2021-02-05
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
Gorman, M. J., Patel, N., Guebre-Xabier, M., Zhu, A., Atyeo, C., Pullen, K., Loos, C., Goez-Gazi, Y., Carrion, R., Tian, J.-H., Yuan, D., Bowman, K., Zhou, B., Maciejewski, S., McGrath, M., Logue, J., Frieman, M., Montefiori, D., Mann, C., Schendel, S., Amanat, F., Krammer, F., Saphire, E. O., Lauffenburger, D. A., Greene, A. M., Portnoff, A. D., Massare, M. J., Ellingsworth, L., Glenn, G., Smith, G., Alter, G.
10.1101/2021.02.05.429759 — Posted: 2021-02-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).